Key Takeaways In 2024, the market for anti-obesity drugs generated a revenue of US$ 26.3 billion , with a CAGR of 31.7% , and is expected to reach US$ 412.9 billion by the year 2034
Further clinical and experimental evidence is necessary to confirm the efficacy and safety of nicotinamide and allopurinol in TAO treatment
Some semaglutide programs include B12 in the compounded formulation specifically because of the increased risk of deficiency
Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis [PMID: 15721419] Laboratory literature summary: Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis
The report explores the Glutathione Market segments (Type, Application and Region)
GLOBAL GLUTATHIONE MARKET SIZE, BY HARD CAPSULES, BY GROUP, 2018-2032 (USD MILLION) TABLE 168